Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD Prophylaxis

Clinical trial NCT05158608 · UNKNOWN

Trial details

NCT number: NCT05158608
Sponsor: National Research Center for Hematology, Russia
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Graft Versus Host Disease Hematologic Malignancy Cyclophosphamide Adverse Reaction

Start date: 2022-01-01
Primary completion: 2024-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.